Markers like neutrophil-derived effectors (RETN), lipocalin-2 (LCN2), and matrix metallopeptidase 8 (MMP8) are among the best predictors of critical illness in COVID-19 provide perhaps the most concrete evidence to date that neutrophil activation is a hallmark of severe disease [20]. This evidence concerns the gene LCN2 and COVID-19.